SK5862000A3 - Dofetilide polymorphs - Google Patents

Dofetilide polymorphs Download PDF

Info

Publication number
SK5862000A3
SK5862000A3 SK586-2000A SK5862000A SK5862000A3 SK 5862000 A3 SK5862000 A3 SK 5862000A3 SK 5862000 A SK5862000 A SK 5862000A SK 5862000 A3 SK5862000 A3 SK 5862000A3
Authority
SK
Slovakia
Prior art keywords
dofetilide
polymorph
substantially pure
mixture
pharmaceutical composition
Prior art date
Application number
SK586-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Ian Colin Appleby
Trevor Jack Newbury
Gary Nichols
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10821150&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK5862000(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of SK5862000A3 publication Critical patent/SK5862000A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
SK586-2000A 1997-10-27 1998-10-09 Dofetilide polymorphs SK5862000A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9722662.5A GB9722662D0 (en) 1997-10-27 1997-10-27 Polymorphs
PCT/EP1998/006641 WO1999021829A1 (en) 1997-10-27 1998-10-09 Dofetilide polymorphs

Publications (1)

Publication Number Publication Date
SK5862000A3 true SK5862000A3 (en) 2001-10-08

Family

ID=10821150

Family Applications (1)

Application Number Title Priority Date Filing Date
SK586-2000A SK5862000A3 (en) 1997-10-27 1998-10-09 Dofetilide polymorphs

Country Status (47)

Country Link
US (1) US6124363A (is)
EP (1) EP1027329B1 (is)
JP (1) JP3569495B2 (is)
KR (1) KR100366167B1 (is)
CN (1) CN1146537C (is)
AP (1) AP906A (is)
AR (1) AR015193A1 (is)
AT (1) ATE232199T1 (is)
AU (1) AU737668B2 (is)
BG (1) BG64125B1 (is)
BR (1) BR9813308A (is)
CA (1) CA2307121C (is)
CO (1) CO4970768A1 (is)
DE (1) DE69811256T2 (is)
DK (1) DK1027329T3 (is)
DZ (1) DZ2632A1 (is)
EA (1) EA002656B1 (is)
ES (1) ES2190620T3 (is)
GB (1) GB9722662D0 (is)
GT (1) GT199800165A (is)
HK (1) HK1033933A1 (is)
HN (1) HN1998000165A (is)
HR (1) HRP20000247B1 (is)
HU (1) HUP0004735A3 (is)
ID (1) ID24658A (is)
IL (1) IL135435A0 (is)
IS (1) IS2179B (is)
MA (1) MA24683A1 (is)
MY (1) MY123352A (is)
NO (1) NO325630B1 (is)
NZ (1) NZ503785A (is)
OA (1) OA11350A (is)
PA (1) PA8462001A1 (is)
PE (1) PE122199A1 (is)
PL (1) PL197379B1 (is)
PT (1) PT1027329E (is)
SA (1) SA98190834B1 (is)
SI (1) SI1027329T1 (is)
SK (1) SK5862000A3 (is)
TN (1) TNSN98193A1 (is)
TR (1) TR200001135T2 (is)
TW (1) TW449589B (is)
UA (1) UA67755C2 (is)
UY (2) UY25222A1 (is)
WO (1) WO1999021829A1 (is)
YU (1) YU24000A (is)
ZA (1) ZA989719B (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019067C1 (de) * 2000-04-18 2001-10-04 Lohmann Therapie Syst Lts Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung
US7326772B2 (en) * 2005-05-12 2008-02-05 Penta Biotech, Inc. Peptide for assaying hERG channel binding
CZ307826B6 (cs) 2017-12-01 2019-05-29 Farmak, A.S. Způsob přípravy N-[4-(2-{[2-(4-methansulfonamidofenoxy)ethyl](methyl)amino}ethyl)fenyl]methansulfonamidu (Dofetilidu)
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
EP0898964A1 (en) * 1997-08-19 1999-03-03 Pfizer Inc. Method for treating heart failure

Also Published As

Publication number Publication date
BR9813308A (pt) 2000-08-22
HK1033933A1 (en) 2001-10-05
PE122199A1 (es) 1999-12-02
TW449589B (en) 2001-08-11
IS5426A (is) 2000-03-31
PL197379B1 (pl) 2008-03-31
UY25222A1 (es) 2000-12-29
US6124363A (en) 2000-09-26
KR20010031439A (ko) 2001-04-16
DE69811256D1 (de) 2003-03-13
IL135435A0 (en) 2001-05-20
KR100366167B1 (ko) 2003-01-09
DZ2632A1 (fr) 2003-03-08
OA11350A (en) 2003-12-17
ATE232199T1 (de) 2003-02-15
NO20002191D0 (no) 2000-04-27
ES2190620T3 (es) 2003-08-01
EP1027329B1 (en) 2003-02-05
AP906A (en) 2000-11-30
BG104373A (en) 2000-12-29
AU2151299A (en) 1999-05-17
JP2001521023A (ja) 2001-11-06
PT1027329E (pt) 2003-04-30
SI1027329T1 (en) 2003-04-30
PA8462001A1 (es) 2000-05-24
UA67755C2 (uk) 2004-07-15
DK1027329T3 (da) 2003-02-24
AP9801371A0 (en) 1998-12-31
MY123352A (en) 2006-05-31
IS2179B (is) 2006-12-15
GT199800165A (es) 2000-04-19
YU24000A (sh) 2003-02-28
AR015193A1 (es) 2001-04-18
CN1278246A (zh) 2000-12-27
UY25341A1 (es) 1999-09-27
BG64125B1 (bg) 2004-01-30
TR200001135T2 (tr) 2000-09-21
TNSN98193A1 (fr) 2005-03-15
EP1027329A1 (en) 2000-08-16
CN1146537C (zh) 2004-04-21
HUP0004735A2 (hu) 2001-10-28
EA002656B1 (ru) 2002-08-29
AU737668B2 (en) 2001-08-30
EA200000365A1 (ru) 2000-12-25
DE69811256T2 (de) 2003-09-18
CO4970768A1 (es) 2000-11-07
WO1999021829A1 (en) 1999-05-06
GB9722662D0 (en) 1997-12-24
PL340805A1 (en) 2001-02-26
HRP20000247B1 (en) 2002-08-31
CA2307121A1 (en) 1999-05-06
NO325630B1 (no) 2008-06-30
HUP0004735A3 (en) 2001-12-28
CA2307121C (en) 2006-12-05
HRP20000247A2 (en) 2000-10-31
NZ503785A (en) 2004-11-26
ID24658A (id) 2000-07-27
NO20002191L (no) 2000-04-27
HN1998000165A (es) 1999-02-09
ZA989719B (en) 2000-04-26
JP3569495B2 (ja) 2004-09-22
SA98190834B1 (ar) 2006-08-21
MA24683A1 (fr) 1999-07-01

Similar Documents

Publication Publication Date Title
CN111936139B (zh) 6-氨基异喹啉的单(酸)盐及其用途
AU2005212229B2 (en) Modafinil compositions
WO1999020620A1 (fr) Derive d'isoquinoleine et medicament
US8809586B2 (en) Modafinil compositions
KR20130108985A (ko) (6，7-디히드로-2-니트로-5ｈ-이미다졸[2,1-ｂ][1,3]옥사진-6-일)아미드 화합물, 그의 제조방법 및 용도
MXPA06002507A (es) Composiciones de modafinil.
KR20230129267A (ko) 리아노딘 수용체 조정제의 결정질 형태 및 그의 용도
TW202200594A (zh) 一種glp-1受體激動劑的晶型a及其製備方法
KR20170033684A (ko) 리나글립틴 결정형 및 이의 제조방법
SK5862000A3 (en) Dofetilide polymorphs
JP6908657B2 (ja) ４−［２−ジメチルアミノ−１−（１−ヒドロキシシクロヘキシル）エチル］フェニル４−メチルベンゾエートヒドロクロリドの多形体、それらを作製する方法及びそれらの使用
EP2292213A1 (en) Compositions comprising a polymorphic form of armodafinil
EP2751094B1 (en) Novel crystal form
CZ20001516A3 (cs) Polymorfy dofetilidu
MXPA00004059A (en) Dofetilide polymorphs
IL199140A (en) Modafinil preparations
NZ519811A (en) 3-phenyl-3, 7-diazabicyclo[3.3.1]nonane or bispidine derivatives for the treatment of cardiac arrythmias
WO2013103004A1 (ja) （２ｅ）－３－（１ｈ－インダゾール－３－イル）－ｎ－（３－メトキシフェニル）－ｎ－［３－（メチルスルホニル）プロピル］ブト－２－エンアミドの結晶形
WO2006070934A1 (ja) 二環性縮合複素環誘導体の結晶、その製造法および用途
NZ548656A (en) A polymorph of R-(-)-modafinil, for use in treating sleep and other disorders